CoChat

ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

Delle Fave, Gianfranco, Kwekkeboom, Dik J., Van Cutsem, Erik, Rindi, Guido, Kos-Kudla, Beata, Knigge, Ulrich, Sasano, Hironobu, Tomassetti, Paola, Salazar, Ramon, Ruszniewski, Philippe · 2012 · Neuroendocrinology

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

Abstract

ed in different studies classified as: duodenal carcinoid; duodenal gastroenteropancreatic (GEP) tumor; duodenal pancreatic neuroendocrine tumor (p-NET); duodenal gastrinoma; duodenal somatostatinoma; gangliocytic paraganglioma; ampullary carcinoid or somatostatinoma; argentaffin carcinoid-producing serotonin of the duodenum; psammomatous somatostatinoma; duodenal NE carcinoma, poorly differentiated and small-cell NE carcinoma of the duodenum [6] . The clinical and management aspect of duodenal gastrinomas are included in the ‘Endocrine Tumors of the Pancreas – Gastrinoma’ section and duodenal gastrinomas will only be considered in this section in comparison with the other d-NENs. Introduction Gastric neuroendocrine neoplasms (g-NENs) [1] are increasingly recognized due to expanding indications of upper gastrointestinal (UGI) endoscopy. Often silent and benign, g-NENs may, however, be aggressive when sporadic and may sometimes mimic the course of gastric adenocarcinoma. Duodenal neuroendocrine tumors (d-NENs) [2] may or may not be associated with a functional clinical syndrome. The term d-NEN includes all duodenal tumors with neuroendocrine (NE) features as determined by histological/immunohistochemical methods including positivity for NE cytosolic markers (neuron-specific enolase (NSE), PGP 9.5) or secretory vesicle proteins (chromogranin A (CgA), synaptophysin) and also frequently the presence of specific gastrointestinal (GI) hormones [3–8] . The term d-NEN in this paper refers to tumors includ- Published online: February 15, 2012 Gianfranco Delle Fave Digestive and Liver Disease Unit ‘Sapienza’ University of Rome, Sant’Andrea Hospital Via Di Grottarossa 1035–1039, IT–00189 Rome (Italy) Tel. +39 06 3377 5691, E-Mail gianfranco.dellefave @ uniroma1.it © 2012 S. Karger AG, Basel 0028–3835/12/0952–0074$38.00/0 Accessible online at: www.karger.com/nen 1

Overview

Integrity signals

Registry

Crossref · 10.1159/000335595

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 139 references

Research works printed but not linked: 30

  1. Attanoos R, 1991, Semin Diagn Pathol, 8, 149
  2. Soga J, 1996, J Exp Clin Cancer Res, 15, 3
  3. Bordi C, 1999, Ital J Gastroenterol Hepatol, 31, S94
  4. Thomas RM, 1994, Cancer, 73, 2053, 10.1002/1097-0142(19940415)73:8<2053::aid-cncr2820730807>3.0.co;2-0 · DOI · Paper page
  5. Cattan D, 1991, Gastroenterol Clin Biol, 15, 30C
  6. Marignani M, 1999, Am J Gastroenterol, 94, 766
  7. Spinazzola AJ, 1963, Am Surg, 29, 405
  8. Walton GF, 1997, Am Surg, 63, 302
  9. Soga J, 1999, J Exp Clin Cancer Res, 18, 13
  10. Taccagni GL, 1986, Am J Gastroenterol, 81, 33
  11. Burke AP, 1990, Arch Pathol Lab Med, 114, 700
  12. Capella C, 1990, Hepatogastroenterology, 37, 247
  13. Heymann MF, 2004, Hepatogastroenterology, 51, 1367
  14. Soga J, 2003, J Exp Clin Cancer Res, 22, 349
  15. Thom AK, 1991, Surgery, 110, 1086
  16. Zogakis TG, 2003, Ann Surg, 238, 42
  17. Gibril F, 2004, Medicine, 83, 43, 10.1097/01.md.0000112297.72510.32 · DOI · Paper page
  18. Cohen T, 1981, Am J Gastroenterol, 75, 197
  19. Amano S, 1978, Acta Pathol Jpn, 28, 721
  20. Orbuch M, 1995, Karger, 23, 268
  21. Yoshikane H, 1995, Am J Gastroenterol, 90, 642
  22. Meijer WG, 2003, J Nucl Med, 44, 184
  23. Lebtahi R, 1999, J Nucl Med, 40, 1602
  24. Hubalewska-Dydejczyk A, 2005, Nucl Med Rev Cent East Eur, 8, 155
  25. Taal BG, 2005, Minerva Gastroenterol Dietol, 51, 335
  26. Sato T, 2005, Hepatogastroenterology, 52, 678
  27. Horsley GW, 1957, Surg Gynecol Obstet, 105, 417
  28. Thompson GB, 1985, Surgery, 98, 1054
  29. Yoshikane H, 1993, Gastrointest Endosc, 39, 375, 10.1016/s0016-5107(93)70109-1 · DOI
  30. Kwekkeboom DJ, 2005, J Nucl Med, 46, 62S

Cited by

See all 328

Metadata

Authors
Delle Fave, G., Kwekkeboom, D. J., Van Cutsem, E., Rindi, G., Kos-Kudla, B., Knigge, U., Sasano, H., Tomassetti, P., Salazar, R., & Ruszniewski, P.
Affiliations
  • Hôpital Louis-Mourier (FR)
  • Agostino Gemelli University Polyclinic (IT)
  • Copenhagen University Hospital (DK)
  • Tohoku University (JP)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Hôpital Beaujon (FR)
Venue
Neuroendocrinology
Publisher
S. Karger AG
Published
2012
Volume
95
Issue
2
Pages
74-87
ISSN
  • 0028-3835 (ISSN-L)
  • 1423-0194
OpenAlex
W2158048233
Cited by
327
References
138
Citations by year
2026: 8 · 2025: 16 · 2024: 14 · 2023: 27 · 2022: 25 · 2021: 22 · 2020: 22 · 2019: 17 · 2018: 18 · 2017: 22 · 2016: 36 · 2015: 45 · 2014: 27 · 2013: 19 · 2012: 9
FWCI
23.95
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
neuroendocrine tumors, consensus recommendations, clinical management, gastrinoma, pancreatic neuroendocrine tumors
MeSH terms
Duodenal Neoplasms, Humans, Stomach Neoplasms, Neuroendocrine Tumors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.